News
Stay up to date on the latest crypto trends with our expert, in-depth coverage.
1Bitget UEX Daily | Trump Pledges to Safeguard Crude Oil Transport; Oil Prices Surge and Pull Back; Gold and Silver Plunge as Dollar Strengthens (March 04, 2026)2Locals prefer satoshis to dollars, says Africa Bitcoin chair Stafford Masie3'No longer a choice': Bitwise CIO says US-Iran strikes put crypto in primary market role
Raytheon Rises on Geopolitical Tensions Despite 80th-Ranked $1.25B Volume Slide
101 finance·2026/03/04 22:42
Seagate Surges 4.86% on Strong Earnings and HAMR Momentum Despite 68th-Ranked $1.43B Volume Drop
101 finance·2026/03/04 22:42
Ariomex data leak exposes 11,826 users
Grafa·2026/03/04 22:42
NRG Energy rises by 0.91% even as trading volume falls by 20.05%, placing its trading activity at 65th position
101 finance·2026/03/04 22:39
Visa's 0.11% Drop and 51st-Ranked Volume Amid Stablecoin Expansion and Undervaluation Debate
101 finance·2026/03/04 22:36
Mastercard’s Strong Earnings Can’t Lift 52nd-Ranked Trading Volume
101 finance·2026/03/04 22:33
Flash
22:40
IREN Ltd has officially signed a market issuance sales agreement, planning to offer ordinary shares to the market with a total value of up to 6 billions USD.This major fundraising initiative has been disclosed in filings with the U.S. Securities and Exchange Commission (SEC). According to the terms of the agreement, IREN Ltd will issue ordinary shares in batches to the public market through underwriters, depending on market conditions and the company's funding needs. This substantial equity financing will provide strong financial support for the company's future strategic expansion and business development.
22:39
According to the latest filing from the U.S. Securities and Exchange Commission (SEC), biotechnology company Tyra Biosciences has reached an agreement to privately issue 4 million common shares to a major investment management firm.The issuance is priced at $31.50 per share, and the transaction details have been officially filed with regulatory authorities. This equity financing marks institutional investors' recognition of Tyra Biosciences' business prospects and will provide funding support for the company's subsequent research and operations.
22:39
According to the latest documents disclosed by the U.S. Securities and Exchange Commission (SEC), The TJX Companies Inc. CEO Ernie Herrman completed a stock transaction on March 2.Herrman sold 30,000 shares of the company's common stock at an average price of $160.95 per share. This transaction complies with relevant regulations and has been officially reported to regulatory authorities through formal documentation.
News